LeadStory
Africanews

Trump funding cuts jeopardize HIV research in South Africa

Africanews · New
Africanews
Africanews
New

At the University of the Witwatersrand, scientists are developing HIV vaccines that could help change the course of the epidemic. But just a week before clinical trials were set to begin, the Trump administration announced it would pull U.S. funding, placing years of critical research in jeopardy.

Breakdown
  • Scientists at the University of the Witwatersrand were about to begin HIV vaccine clinical trials when U.S. funding was withdrawn. 7s
  • The Trump administration's decision places years of critical HIV research at risk. 14s
  • South Africa's research community faces challenges in securing alternative funding. 28s
  • Funding cuts have already led to the loss of 8,000 HIV health workers in South Africa. 1m 9s
  • The South African government warns that without U.S. funding, HIV infections may rise and access to medication could decline. 1m 46s
HealthInternational PoliticsMedical Research